Welcome to our dedicated page for Avant Brands news (Ticker: AVTBF), a resource for investors and traders seeking the latest updates and insights on Avant Brands stock.
News and updates for Avant Brands Inc. (OTCQX: AVTBF) focus on its activities as a premium cannabis producer with operations across Canada and a growing international presence. Company announcements frequently highlight developments in recreational, medical, and export markets, reflecting Avant’s role in the cannabis sector and its listing on the Toronto Stock Exchange, OTCQX Best Market, and Frankfurt Stock Exchange.
Investors following Avant’s news can expect regular coverage of financial results, including quarterly and annual updates where the company reports on gross and net revenue, export wholesale revenue, cannabis production and sales volumes, and non-GAAP performance measures such as adjusted EBITDA and adjusted net income. These releases often discuss trends in domestic wholesale, recreational revenue, and international sales.
Avant’s news flow also includes strategic and commercial milestones. Examples disclosed by the company include multi-year international supply agreements for GACP-certified dried flower, licensing agreements for its BLK MKT™ brand in overseas markets, and SKU expansions for BLK MKT™ and Tenzo™ in Canadian provinces such as Ontario and British Columbia. The company has also reported on medical platform initiatives under the Avant Medical and GreenTec™ banners.
Corporate and capital markets updates appear in Avant’s news as well, such as annual general meeting results, changes to incentive plans, amendments to warrants and convertible debentures, and the adoption of a shareholder rights plan. Debt-related announcements, including the full repayment of a secured convertible debenture tied to a prior acquisition, have also been featured.
For readers tracking AVTBF, this news stream offers insight into Avant’s operational performance, international expansion, product portfolio evolution, and corporate governance decisions. Regularly reviewing these items can help contextualize the company’s position within the cannabis industry and its strategic priorities over time.
Avant Brands (TSX:AVNT, OTCQX:AVTBF) has announced its annual general and special meeting scheduled for May 30, 2025, at 1:00 p.m. PDT in Kelowna, BC. Key highlights include proposed amendments to previously issued convertible securities:
The company has entered into Repricing Amendments on April 21, 2025, affecting:
- Warrants: Exercise price reduction from $3.00 to $1.75
- Convertible Debentures: Staged conversion price reductions from $3.00 to:
- $1.25 (first 3 months post-approval)
- $1.50 (3-6 months post-approval)
- $1.75 (6 months to maturity)
These amendments remain subject to TSX and shareholder approval. Shareholders of record as of April 14, 2025, will be eligible to vote at the meeting. Meeting materials will be available on the company's website and SEDAR+.
Avant Brands (AVTBF) has reported its Q1 2025 financial results, showing notable growth in several key metrics. Gross Revenue increased 8% to $9.7 million, while Net Revenue rose 7% to $8.6 million compared to Q1 2024.
The company's Export Wholesale Revenue saw significant growth, reaching $4.7 million (+41%), driven by strong demand in Australia, Germany, and Israel. However, Recreational Revenue declined 16% to $2.8 million, and Domestic Wholesale Revenue decreased 28% to $0.9 million following a strategic SKU realignment.
Financial highlights include a Gross Profit increase to $1.6 million (from $0.9 million), marking the fifth consecutive quarter of positive Adjusted EBITDA ($1.7 million) and Adjusted Net Income ($0.5 million). Cannabis production reached 3,326 KG (+3%), with sales volume up 21% to 3,360 KG. The Gross Margin percentage adjusted for fair value adjustments decreased to 34% from 58% due to market price compression and increased cultivation costs.
Avant Brands reported record financial results for fiscal year 2024, with gross revenue reaching $40.0 million (+32% YoY) and net revenue of $35.8 million (+36% YoY). The company achieved significant growth in export wholesale revenue, reaching $19.4 million (+107% YoY), driven by strong international demand from Australia, Germany, and Israel.
Q4 2024 highlights include record gross revenue of $12.1 million (+109% YoY) and net revenue of $11.0 million (+127% YoY). However, the company reported a gross loss of $1.8 million in Q4 2024, compared to a $1.0 million profit in Q4 2023, primarily due to biological asset valuations.
Cannabis production increased 19% to 12,643 kg in FY 2024, while sales volume grew 91% to 13,560 kg. The company maintained positive Adjusted EBITDA and Adjusted Net Income for four consecutive quarters, with Q4 2024 achieving $2.3 million and $2.7 million respectively.
Avant Brands (TSX:AVNT) (OTCQX:AVTBF) reported record financial results for Q3 2024, ending August 31, 2024. Highlights include:
- Record gross revenue of $9.6 million (+27% YoY)
- Record net revenue of $8.5 million (+30% YoY)
- Record export wholesale revenue of $5.1 million (+116% YoY)
- Record cannabis production of 3,441 kg (+5% YoY)
- Record cannabis sales of 3,087 kg (+98% YoY)
The company's growth was driven by strong international demand, particularly in Australia, Germany, and Israel. Avant achieved an Adjusted EBITDA of $2.1 million and Adjusted Net Income of $0.5 million. The company's cash balance increased by $2.4 million year-to-date. Avant continues to expand its global footprint, executing nine international agreements and shipping products to four new clients.
Avant Brands Inc. has entered an exclusive trademark licensing agreement with Nectar Portfolio Pty to introduce its BLK MKT™ brand to the Australian medical cannabis market. This expands Avant's global footprint, with BLK MKT™ now available in Canada, Australia, Germany, Israel, and Switzerland, reaching a combined population of about 127 million.
Key highlights include:
- Nectar's exclusive rights to market, sell, and distribute BLK MKT™ dried cannabis flower in Australia for two years
- Products will be cultivated by Avant in Canada, meeting Australian medicinal cannabis standards
- Avant will receive its standard international sales price plus a royalty fee on Nectar's net sales
This partnership is expected to generate incremental revenue growth for Avant Brands and establish BLK MKT™ as a leading global cannabis brand.
Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) has announced a 30:1 share consolidation effective August 30, 2024. The consolidation, approved by the board of directors, will reduce the company's outstanding common shares from 316,342,373 to approximately 10,544,745. No shareholder approval is required. Fractional shares will be rounded up or down based on a 0.5 threshold. Registered shareholders will receive instructions for exchanging their shares, while those holding shares through brokers need not take action. The company's warrants, options, and convertible securities will be adjusted proportionately. Trading on the TSX under the new ISIN CA05353D2023 and CUSIP 05353D202 is expected to commence on the effective date, subject to regulatory approvals.
Avant Brands (TSX:AVNT)(OTCQX:AVTBF) has successfully closed a $3.9 million non-brokered private placement of unsecured convertible debenture units. Each unit, priced at $1,000, comprises a $1,000 principal amount convertible debenture and 10,000 common share purchase warrants. The debentures are convertible at $0.10 per share and bear a 10% annual interest rate. Warrants are exercisable at $0.10 per share for 48 months. The company plans to use the proceeds to repay existing debt. CEO Norton Singhavon views this as a significant milestone, potentially enabling expansion into international markets and accelerating growth.
Avant Brands (TSX:AVNT)(OTCQX:AVTBF) has announced a $3.9 million private placement of unsecured convertible debenture units. Each unit, priced at $1,000, includes a $1,000 principal amount convertible debenture and 10,000 warrants. The debentures are convertible into shares at $0.10 per share, while warrants are exercisable at $0.10 for 48 months.
Key features include:
- 10% annual interest rate, paid quarterly
- 6.25% of principal repaid quarterly
- 4-year maturity
- 9.99% beneficial ownership limit for the subscriber
The placement is expected to close around July 19, 2024, with proceeds used to repay existing debt. The deal is subject to TSX approval.
Avant Brands (TSX:AVNT)(OTCQX:AVTBF) reported record financial results for Q2 2024, ending May 31. Highlights include:
- Record gross revenue of $9.4 million, up 5% year-over-year
- Record net revenue of $8.3 million, up 4%
- International sales reached a record $3.7 million, up 26%, now 45% of net revenue
- Record Cash Flow from Operations of $4.6 million
- Record Adjusted Net Income of $1.4 million
- Adjusted EBITDA of $2.8 million, with a 34% margin
The company's success is driven by strong international demand for premium cannabis products, particularly in Australia, Germany, and Israel. Avant has executed 9 new international agreements in fiscal 2024, expanding into European markets like Poland, UK, and Czech Republic.